Investigating the Association of ApoE Genotypes with Blood-Brain Barrier Dysfunction Measured by Cerebrospinal Fluid-Serum Albumin Ratio in a Cohort of Patients with Different Types of Dementia

Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias

(2012) M. Yarchoan et al.   BRAIN

Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease

(2012) Valerio Pisani et al.   Journal of Neuroinflammation

A breach in the blood–brain barrier

(2012) Peter Carmeliet et al.   NATURE

APOE and Alzheimer disease: a major gene with semi-dominant inheritance

(2011) E Genin et al.   MOLECULAR PSYCHIATRY

The Association of APOE Genotype with Cognitive Function in Persons Aged 35 Years or Older

(2011) Gerbrand J. Izaks et al.   PLoS One

Cardiopulmonary Bypass Increases Permeability of the Blood-Cerebrospinal Fluid Barrier

(2009) Toru Okamura et al.   ANNALS OF THORACIC SURGERY

Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease

(2009) I. Zerr et al.   BRAIN

Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

(2009) Guojun Bu   NATURE REVIEWS NEUROSCIENCE

Is it appropriate to use albumin CSF/plasma ratio to assess blood brain barrier permeability?

(2009) Ruo-Li Chen   NEUROBIOLOGY OF AGING

Genetic Association Studies

(2008) Kathryn L. Lunetta   CIRCULATION

Apolipoprotein E, Amyloid-β, and Blood-Brain Barrier Permeability in Alzheimer Disease

(2008) John E. Donahue et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

The association of APOE genotype and cognitive decline in interaction with risk factors in a 65–69 year old community sample

(2008) Helen Christensen et al.   BMC Geriatrics

Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis

(2007) Andrew J. Farrall et al.   NEUROBIOLOGY OF AGING